MedTrace Logo

The Effect of Masking on Subjective Results During Daily Disposable Contact Lens Studies

NCT01155726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2012-07-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to explore the effect of masking on subjective ratings for two daily disposable contact lenses.

Conditions

  • Myopia
  • Hyperopia

Interventions

DEVICE

Nelfilcon A contact lens

Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.

DEVICE

Nelfilcon A contact lens with comfort additive (DACP), unmasked

Commercially marketed, soft, hydrogel contact lens with comfort additive for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses and removed inserted by participant.

DEVICE

Nelfilcon A contact lens with comfort additive (DACP), masked

Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.

DEVICE

Nelfilcon A contact lens with comfort additive (DACP), partially masked

Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Lens name and manufacturer on blister pack label concealed from participant. Lenses inserted and removed by the participant.

DEVICE

Etafilcon A contact lens

Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.

DEVICE

Etafilcon A contact lens with comfort additive (1DAVM), unmasked

Commercially marketed, soft, hydrogel contact lens with comfort additive for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.

DEVICE

Etafilcon A contact lens with comfort additive (1DAVM), masked

Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.

DEVICE

Etafilcon A contact lens with comfort additive (1DAVM), partially masked

Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Lens name and manufacturer on blister pack label concealed from participant. Lenses inserted and removed by the participant.

Sponsors & Collaborators

  • CIBA VISION

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01155726 on ClinicalTrials.gov